Research graph
References from Chocolate Balloon Versus Conventional Balloon for Vessel Preparation Before Drug-Coated Balloon Angioplasty in Femoropopliteal Lesions: A Real-World Propensity Score–Matched Study. Local targets link to admitted publications; unresolved targets remain external evidence.
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
10.1016/s0140-6736(13)61249-0 · 2013 · External reference
Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies
10.1161/circulationaha.117.028893 · 2017 · External reference
Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease
10.1056/nejmoa1406235 · 2015 · External reference
Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial
10.1161/circulationaha.114.011004 · 2015 · External reference
Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease
10.1007/s00270-014-0904-3 · 2014 · External reference
Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery
10.1016/j.jvs.2014.01.041 · 2014 · External reference
Prevalence and clinical impact of stent fractures after femoropopliteal stenting
10.1016/j.jacc.2004.11.026 · 2005 · External reference
Classification and clinical impact of restenosis after femoropopliteal stenting
10.1016/j.jacc.2011.09.036 · 2012 · External reference
A prospective, multi-center study of the chocolate balloon in femoropopliteal peripheral artery disease: The Chocolate BAR registry
10.1002/ccd.27565 · 2018 · External reference
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
10.1186/s42155-022-00324-z · 2022 · External reference
Early Experience with a New Concept of Angioplasty Nitinol-Constrained Balloon Catheter (Chocolate(®)) in Severely Claudicant Patients
10.1007/s00270-017-1840-9 · 2018 · External reference
Specialty Balloons Versus Plain Old Balloon Angioplasty for Vessel Preparation Before Drug-Coated Balloon Therapy in Femoropopliteal Occlusive Disease
10.1016/j.amjcard.2025.09.054 · 2025 · External reference
Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis: Predictors and Outcomes from a Multicenter Study
10.1016/j.jvir.2026.108836 · 2026 · External reference
SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions
10.1002/ccd.27635 · 2018 · External reference
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
10.1161/cir.0000000000001251 · 2024 · External reference
The Impact of Balloon Pre-dilatation Techniques on Drug-Coated Balloon Therapy for Femoropopliteal Artery Disease: Six-Month Results From the CIVILIAN Registry
10.1177/15266028241231036 · 2025 · External reference
Combined chocolate drug-coated balloon treatment of femoropopliteal artery lesions in patients with Rutherford Grade 3-6
10.1024/0301-1526/a001196 · 2025 · External reference
Application of the chocolate balloon (restrictive dilatation technique) in vascular preparation for arterial angioplasty of the lower limbs
10.3389/fsurg.2025.1528231 · 2025 · External reference
Clinical outcomes in patients with chronic limb-threatening ischemia after femoropopliteal intervention with a drug-coated balloon or stenting
10.1016/j.jvs.2025.02.010 · 2025 · External reference
